Norwegian Cruise Line Holdings Ltd. Announces Plan for Long-Awaited Return to Cruising in the U.S.

NEXT STORY
Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer
PREV STORY
United States COVID-19 Vaccines and Therapeutics Market Tracker: Q2, 2021 Report – Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

  PRESS RELEASE: 23 May 2017, 07:00 CEST Biocartis launches CE-marked IVD NRAS test for colorectal ...

author_avatar
NASDAQ Market News

TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure

PRESS RELEASE TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure Leuven ...

author_avatar
NASDAQ Market News

Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK™ (sodium thiosulfate) Presented at the 49th Congress of the International Society of Pediatric Oncology (SIOP) 2017 Meeting

Study met primary endpoint (p=0.0033) Significant reduction in cisplatin induced hearing loss without any ...

author_avatar
NASDAQ Market News